Heart Disease News and Research

Latest Heart Disease News and Research

Recent releases in Global Health

The WHO's March Bulletin is a special themed issue focusing on communicable diseases in Southeast Asia. The publication addresses tuberculosis, cholera, neglected tropical diseases and family planning in the region (March 2010).

6 Mar 2010

Adults with depression and diabetes face increase risk of dementia

Adults who have both diabetes and major depression are more than twice as likely to develop dementia, compared to adults with diabetes only, according to a study published in the recent Journal of General Internal Medicine.

6 Mar 2010

McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseases

Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.

6 Mar 2010

It Starts with the Heart: Community initiative launched to support not-for-profits of all sizes

Health Diagnostic Laboratory Inc., www.hdlabinc.com, has launched a community initiative known as It Starts with the Heart, a company-wide commitment to support not-for-profits of all sizes in making a difference in their community.

6 Mar 2010

Poll: On health reform, Americans trust Obama more than both parties in Congress

A new Gallup poll asked Americans whom they trusted to reform the nation's health care system.

5 Mar 2010

AMICAS and Merge Healthcare sign definitive merger agreement

AMICAS, Inc. and Merge Healthcare Incorporated (Nasdaq: MRGE) today announced that they will enter into a definitive merger agreement pursuant to which Merge will acquire all of the outstanding shares of AMICAS for $6.05 per share in cash, or an aggregate of $248 million.

5 Mar 2010

Data to advance the diagnosis, treatment and management of MH to be presented

Travel Award Available to share data with Clinicians and Scientists to advance the diagnosis, treatment, and management of Malignant Hyperthermia-Susceptible Patients April 23-24, 2010 at Mercy Hospital University of Pittsburgh Medical Center.

5 Mar 2010

Promises Treatment Center CEO's insights on Redmond O'Neal's addiction and rehabilitation problems

The unfortunate story of Redmond O'Neal continues to make headlines. He has been an admitted addict since he was a teen and has had multiple drug arrests. He recently appeared in court for a status hearing on his latest stint in rehab.

5 Mar 2010

Boar's Head promotes healthy lifestyle options and helps champion the cause of diabetes prevention

Boar's Head, a leader in developing fine deli products that respond to consumers' health and wellness concerns, announces an initiative to reach the growing number of Americans now following a gluten free way of life. "Gluten Free with Boar's Head," is reaching out to gluten free followers with news that Boar's Head meats, cheeses and condiments are, and always have been, gluten free.

5 Mar 2010

Glencoe Enterprise article highlights medical innovation and research enable people to live longer, healthier

An article in the Glencoe Enterprise recently highlighted the fact that medical innovation and research are enabling many people to live longer, healthier and more productive lives.

5 Mar 2010

FDA takes steps to protect consumers from potential Salmonella infection

The U.S. Food and Drug Administration is taking steps to protect the public following the early identification of Salmonella Tennessee in one company's supply of hydrolyzed vegetable protein (HVP). This is a common ingredient used most frequently as a flavor enhancer in many processed foods, including soups, sauces, chilis, stews, hot dogs, gravies, seasoned snack foods, dips and dressings.

5 Mar 2010

Joint Hearing of Senate and House Committees on Veterans’ Affairs: MOPH National Commander testifies

On Thursday, March 4, 2010, National Commander Jim Sims will testify on behalf of the Military Order of the Purple Heart (MOPH) before a Joint Hearing of the Senate and House Committees on Veterans’ Affairs.

5 Mar 2010

Proper treatment can help control psoriasis in most cases

For the approximately 7.5 million Americans affected by psoriasis, the thick, red, scaly, itchy plaques it causes only scratch the surface when it comes to the overall implications of this disease. Now, ongoing research linking psoriasis to other serious medical conditions and the incredible toll it can take on a person's overall quality of life are shifting the way psoriasis is viewed - from a common skin disease to a complex systemic condition.

5 Mar 2010

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

The Heart and Stroke Foundation (HSF) is concerned with the lack of any substantive funding in support of heart health initiatives as outlined in today's 2010 Federal Budget.

5 Mar 2010

Endothelial cells can produce copious amounts of adult stem cells: Study

In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

5 Mar 2010

Transcendental Meditation technique produces unique state of "restful alertness"

A new EEG study conducted on college students at American University found they could more highly activate the default mode network, a suggested natural "ground state" of the brain, during their practice of the Transcendental Meditation technique. This three-month randomized control study is published in a special issue of Cognitive Processing dedicated to the Neuroscience of Meditation and Consciousness, Volume 11, Number 1, February, 2010.

5 Mar 2010

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.

5 Mar 2010

Gene involved in susceptibility and resistance to TB identified

University of Washington researchers have identified a gene involved in susceptibility and resistance to tuberculosis. This same gene, they have found, has a role in the severity of leprosy, which is caused by a related pathogen. The researchers also have learned why this gene is important for susceptibility.

5 Mar 2010

TransMedics closes $36M financing round

TransMedics, Inc., a leading medical device company focusing on delivering the next standard of care for solid organ transplantation worldwide, announced today the closing of a $36 million financing round. The financing was lead by Foundation Capital and Kleiner Perkins Caufield & Byers (KPCB) and also included investments by Flagship Ventures and by several existing investors.

5 Mar 2010

KAPIDEX to be marketed as DEXILANT in the U.S.

Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

5 Mar 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Recent releases in Global Health

Adults with depression and diabetes face increase risk of dementia

McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseases

It Starts with the Heart: Community initiative launched to support not-for-profits of all sizes

Poll: On health reform, Americans trust Obama more than both parties in Congress

AMICAS and Merge Healthcare sign definitive merger agreement

Data to advance the diagnosis, treatment and management of MH to be presented

Promises Treatment Center CEO's insights on Redmond O'Neal's addiction and rehabilitation problems

Boar's Head promotes healthy lifestyle options and helps champion the cause of diabetes prevention

Glencoe Enterprise article highlights medical innovation and research enable people to live longer, healthier

FDA takes steps to protect consumers from potential Salmonella infection

Joint Hearing of Senate and House Committees on Veterans’ Affairs: MOPH National Commander testifies

Proper treatment can help control psoriasis in most cases

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

Endothelial cells can produce copious amounts of adult stem cells: Study

Transcendental Meditation technique produces unique state of "restful alertness"

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Gene involved in susceptibility and resistance to TB identified

TransMedics closes $36M financing round

KAPIDEX to be marketed as DEXILANT in the U.S.

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in